BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12913349)

  • 1. Effect of alpha-fetoprotein and derived peptides on insulin- and estrogen-induced fetotoxicity.
    Butterstein G; Morrison J; Mizejewski GJ
    Fetal Diagn Ther; 2003; 18(5):360-9. PubMed ID: 12913349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
    Mizejewski G; Smith G; Butterstein G
    Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.
    Yachnin S
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-efficient expression, refolding and purification of functional recombinant C-terminal fragment of human alpha-fetoprotein.
    Sharapova OA; Pozdnykova NV; Laurinavichyute DK; Yurkova MS; Posypanova GA; Fedorov AN; Severin SE; Severin ES
    Protein Expr Purif; 2010 Sep; 73(1):31-5. PubMed ID: 20363333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation.
    Yachnin S; Lester EP
    J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational transitions of human alpha-1 fetoprotein and serum albumin at acid and alkaline pH.
    Strop P; Zizkovský V; Korcáková J; Havranová M; Mikes F
    Int J Biochem; 1984; 16(7):805-13. PubMed ID: 6205912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
    Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
    Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
    Lester EP; Miller JB; Yachnin S
    Immunol Commun; 1978; 7(2):137-61. PubMed ID: 77248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synergic effect of adenoviral vector-encoding human alpha-fetoprotein and interferon-gamma on immunity against hepatocellular carcinoma in mice].
    Tan XH; Zhu Q
    Ai Zheng; 2008 Feb; 27(2):155-9. PubMed ID: 18279612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purification and characterization of recombinant human alpha-fetoprotein fragment, corresponding to the C-terminal structural domain].
    Sharapova OA; Pozdniakova NV; Laurinavichiute DK; Iurkova MS; Posypanova GA; Andronova SM; Fedorov AN; Severin SE; Severin ES
    Bioorg Khim; 2010; 36(6):760-8. PubMed ID: 21317941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous insulin treatment on fetal growth and maternal alpha-fetoprotein levels in pregnant mice.
    Andersen LL; Buschard K; Hau J
    Biomed Biochim Acta; 1991; 50(7):901-6. PubMed ID: 1722093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of murine feto-placental growth by pregnancy-specific serum proteins in an experimentally induced fetal growth retardation model.
    Andersen LL; Poulsen OM; Hau J
    In Vivo; 1988; 2(6):367-70. PubMed ID: 2485137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome.
    Mizejewski GJ
    Exp Biol Med (Maywood); 2007 Sep; 232(8):993-1004. PubMed ID: 17720945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting.
    Straus DS; Ooi GT; Orlowski CC; Rechler MM
    Endocrinology; 1991 Jan; 128(1):518-25. PubMed ID: 1846108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants.
    Lester EP; Miller JB; Yachnin S
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4645-8. PubMed ID: 63952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
    Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation.
    Yachnin S; Getz GS; Lusk L; Hsu RC
    Oncodev Biol Med; 1980; 1(4-5):273-85. PubMed ID: 6169064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene fusion method to screen for regulatory effects on gene expression: application to the LDL receptor.
    Li K; Ramirez MA; Rose E; Beaudet AL
    Hum Mol Genet; 2002 Dec; 11(26):3257-65. PubMed ID: 12471052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
    Mizejewskia GJ; Butterstein G
    Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human fetal and tumor alpha-fetoproteins differ in conformationally dependent epitope variants expression.
    Yazova AK; Goussev AI; Christiansen M; Kushlinsky NE; Stogova E; Norgaard-Pedersen B; Abelev GI
    Immunol Lett; 2003 Feb; 85(3):261-70. PubMed ID: 12663141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.